Guggenheim analyst Sandy Draper upgrades Medpace Hldgs (NASDAQ:MEDP) from Neutral to Buy and announces $252 price target.
Guggenheim Upgrades Medpace Hldgs to Buy, Announces $252 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.